Introduction
Internationally,G ermanyisamong the countriesw ithavery high prevalenceofobesity.Germanyhasthe highest prevalenceofobesity in Europe.The GermanHealthSurveydatafrom 2003 indicate thatt he prevalenceo fo besity is6 0%,with70%o fm en and 50% of women being obese [1] . 
Status of BariatricSurgery in Germany-

Materialand Methods
The ongoing Germanm ulticenterobservationalstudyw asinitiated asa meansof quality assurancei no besity surgery on January 1,2005 [8] .The datawerecollected prospectivelyats urgicald epartments and hospitals throughout Germanyusing anonline datab ank. Inthe trial,primary bariatricoperationsasw ell asr evisionalp roceduresw ereregistered. Long-term complicationsw ered ocumented in patients who underwentprimary bariatricsurgery beforeJanuary 1,2005. Priort oe nrollment,eachp atients igned ac onsentform. The studyw asconducted according tothe recommendationsof the Declaration of Helsinkifor BiomedicalResearchand the guidelinesand standardsof the Institutional ReviewBoards. Follow-upd ataa bout weightloss,a melioration of comorbidities,a nd longtermcomplicationswerecollected annually.
Results
The dataof the Germanm ulticenterobservationalstudyforquality assuranceinobesity surgery wasobtained during the studyperiod from 2005to2007.The numberof hospitalsparticipating every yeariss howni ntable 1. Hospitalst hatt ook part in the voluntary multicentertrialareshowninfigure1. Overt he years therewasavarying distribution of hospitalsand centers thatprovide bariatricsurgery in the various regionsof Germany (table 2) Incomparison withresults from apublished meta-analysis,b ariatricpatients in Germanyweresignificantlyolder (table 7) . Inaddition,BMI wassignificantlyhigherand morepatients suffered from diabetesand hypertension (table 8) [9, 10] .Thismightexplain why moreRYGBP thanGB proceduresw erep erformed in 2007.The influenceo fh igh BMI and the high rateo fcomorbiditiesmust be considered when evaluating the data, in particulart hoseo btained in the long-termf ollow-upi nvestigation of persistenteffects on weightr eduction and amelioration of comorbidities.Afterr estrictivep rocedures,the weightloss observed wasless thanthatr eported in the literature,a nd the factors mentioned aboveh aveto betaken intoaccount.
The studydataobtained between 2005and 2007 showt hatt here wasatendencytoshiftfrom restrictivetom oremalabsorptiveo perations.Thiseffectseemed tobeinfluenced bythe high preoperativeBMI of Germanpatients. The increasing long-termcomplicationsafterGB werealsod etected in the studypresented here. The numberof required reoperationsafterGB isincreasing. Thisisr eflected in the data obtained forpatients who underwentGB beforeJanuary 1,2005. According tothe datafrom the literature,the frequencyof reoperationsincreased upto2%foreachyearof follow-up [11] . AfterSG the frequencyof generalcomplicationswas14.1%. Leaks occurred in 7%o fthe studyparticipants.SG isahigh-riskp roceduremostlyperformed asafirst step in high-riskpatients.InaGermantrial,2patients died afterSG and thereforethe mortality was 1.6%. The reported mortality rateafterSG ranged from 0.0%to 3.6%i nthe literature [12] .The impactof gender,a ge,B MI, and comorbiditieson weightloss hast obee valuated in futurestudies. Mortality afterDS doesnotdifferfrom mortality afterSG in the literature,however,morbidity afterSG ismuchh ighert hanm orbidity afterDS [12] . The incidenceo fRML hasbeen reported torange from 0.9% to 22.7% [13] .Inthe presents tudy,the mortality associated with RML was0.06%. Asthisstudywasbased on voluntary participation,itisvery likely thatthe actualmortality ishigherthanthatreported here. Follow-upd atawereavailable foratotalo f9 29( 63.8%) patients. Thismeansthat28.3%ofthe patients werelost tofollow-upinvestigation by1yearpostoperatively,whichm ightbeconsidered asa 
